Henry Schein, Inc.
Profit after direct costs
Core business profitability
Bottom line profitability
Top line growth rate
Flow of revenue through cost categories to net income
| Item | Trend | 2021 | 2022 | 2023 | 2024 | 2025 | YoY Change |
|---|---|---|---|---|---|---|---|
Total Revenue | 12.40B | 12.65B | 12.34B | 12.67B | 13.18B | 4.0% | |
| Cost of Revenue | (8.73B) | (9.00B) | (8.69B) | (8.91B) | (9.34B) | 4.9% | |
Gross Profit | 3.67B | 3.65B | 3.65B | 3.77B | 3.84B | 2.0% | |
| Operating Expenses | |||||||
| Research & Development | — | — | — | — | — | — | |
| Selling, General & Administrative | (2.82B) | (2.71B) | (2.94B) | (3.04B) | (3.08B) | 1.6% | |
| Depreciation & Amortization | (209.53M) | (212.00M) | (248.00M) | (297.00M) | (311.00M) | 4.7% | |
Operating Income (EBIT) | 854.81M | 938.00M | 714.00M | 729.00M | 758.00M | 4.0% | |
| Non-Operating Items | |||||||
| Interest Income | 6.45M | 17.00M | 17.00M | 24.00M | 33.00M | 37.5% | |
| Interest Expense | (27.60M) | (44.00M) | (87.00M) | (131.00M) | (150.00M) | 14.5% | |
| Other Income/Expenses (Net) | -4.25M | -202.00M | -158.00M | -203.00M | -213.00M | 4.9% | |
Income Before Tax | 850.56M | 736.00M | 556.00M | 526.00M | 545.00M | 3.6% | |
| Income Tax Expense | (197.35M) | (170.00M) | (120.00M) | (128.00M) | (126.00M) | -1.6% | |
Net Income | 623.91M | 538.00M | 416.00M | 390.00M | 398.00M | 2.1% | |
| Per Share Metrics | |||||||
| Earnings Per Share (Basic) | $5 | $4 | $3 | $3 | $3 | 7.2% | |
| Weighted Avg Shares Outstanding | 140.09M | 136.06M | 130.62M | 126.79M | 120.81M | -4.7% | |
| Weighted Avg Shares Outstanding (Diluted) | 141.77M | 137.76M | 131.75M | 127.78M | 121.72M | -4.7% | |
EBITDA | 1.07B | 977.00M | 877.00M | 941.00M | 1.01B | 6.9% |
Explore HSIC
HSIC in the Healthcare
Mid Cap